Search

everythinglearnresearchcommunity

for

Search:↓

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Treating cystoid macular oedema in uveitis is difficult and risky.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Fetal cells could improve skin repair with minimal scarring and are a potential ready-to-use solution for tissue engineering.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.